AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A.B. who wrote (353)	8/7/1997 9:17:00 PM
From: Mike Heimbuch	of 2173

Hello Michael J Thanks for taking time to respond. I certainly appreciate Mr. Niman's viewpoint garnered from looking at the web site. There is always the possibility of fraud in this world. On the other hand I have worn folks out on the phone who are associated in some fashion with this company and have yet to find an indication of either slickness or impropriety. What interests me most is the attention that Merck and Novonordisk are paying to this little enterprise - and this has been verified by a number of sources - including one who was comfortable evough to line up a million in financing lately. China is not only a huge market for diabetes drugs - one of the main folks in BIO appears to be well connected there. If this is a BRE-X story - why is there absolutely no sales hype coming from anywhere here?? I want to know what is wrong - if anything - with their science. If anyone has time or inclination to research this once in a while - I would appreciate further input. thanks Mike in Alaska

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next